We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+9.54%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$109B
AUM Growth
+$10.1B
Cap. Flow
+$2.06B
Cap. Flow %
1.89%
Top 10 Hldgs %
23.41%
Holding
4,156
New
227
Increased
1,649
Reduced
1,885
Closed
242

Sector Composition

Rank Sector Weight
1 Technology 12.51%
2 Healthcare 9.35%
3 Financials 9.21%
4 Industrials 6.82%
5 Consumer Discretionary 5.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CXE
3226
DELISTED
MFS High Income Municipal Trust
CXE
$292K ﹤0.01%
83,545
+40,859
+96% +$140K
EE icon
3227
Excelerate Energy
EE
$1.12B
$291K ﹤0.01%
+11,614
New +$305K
HPK icon
3228
HighPeak Energy
HPK
$947M
$290K ﹤0.01%
12,700
-1,500
-11% -$33.7K
IXG icon
3229
iShares Global Financials ETF
IXG
$702M
$290K ﹤0.01%
4,124
+253
+7% +$17.3K
EMLC icon
3230
VanEck JP Morgan EM Local Currency Bond ETF
EMLC
$4.79B
$289K ﹤0.01%
11,947
-199
-2% -$4.67K
GRAB icon
3231
Grab
GRAB
$15.1B
$289K ﹤0.01%
89,888
-1,303
-1% -$3.73K
KTOS icon
3232
Kratos Defense & Security Solutions
KTOS
$11.8B
$289K ﹤0.01%
27,986
+12,800
+84% +$127K
GDS icon
3233
GDS Holdings
GDS
$6.97B
$289K ﹤0.01%
+13,996
New +$214K
ALX
3234
Alexander's
ALX
$1.4B
$288K ﹤0.01%
1,311
+24
+2% +$5.48K
HELE icon
3235
Helen of Troy
HELE
$699M
$288K ﹤0.01%
2,600
-429
-14% -$41.8K
XPH icon
3236
State Street SPDR S&P Pharmaceuticals ETF
XPH
$511M
$288K ﹤0.01%
7,037
+1,520
+28% +$63.3K
LICY
3237
DELISTED
Li-Cycle Holdings Corp.
LICY
$288K ﹤0.01%
7,564
-392
-5% -$17.6K
ATMP icon
3238
iPath Select MLP ETN
ATMP
$640M
$288K ﹤0.01%
+15,339
New +$291K
GSL icon
3239
Global Ship Lease
GSL
$1.49B
$287K ﹤0.01%
17,232
-4,029
-19% -$69.3K
IYLD icon
3240
iShares Morningstar Multi-Asset Income ETF
IYLD
$126M
$286K ﹤0.01%
15,094
-127,498
-89% -$2.41M
DVN icon
3241
CALL
Devon Energy
DVN
$48.8B
$286K ﹤0.01%
285,900
+20,300
+8% +$1.38M
RPRX icon
3242
Royalty Pharma
RPRX
$26.1B
$286K ﹤0.01%
7,240
-7,388
-51% -$308K
SPXC icon
3243
SPX Corp
SPXC
$10.6B
$286K ﹤0.01%
4,358
-750
-15% -$49.1K
VICI icon
3244
CALL
VICI Properties
VICI
$29B
$286K ﹤0.01%
81,700
-2,100
-3% -$67.5K
GBX icon
3245
The Greenbrier Companies
GBX
$1.42B
$285K ﹤0.01%
8,499
-181
-2% -$6.03K
RVNU icon
3246
Xtrackers Municipal Infrastructure Revenue Bond Active ETF
RVNU
$144M
$285K ﹤0.01%
11,988
-3,052
-20% -$71.7K
CIVB icon
3247
Civista Bancshares
CIVB
$595M
$285K ﹤0.01%
+12,934
New +$292K
EMF
3248
Templeton Emerging Markets Fund
EMF
$332M
$284K ﹤0.01%
24,846
+9,123
+58% +$102K
VRTV
3249
DELISTED
VERITIV CORPORATION
VRTV
$283K ﹤0.01%
+2,328
New +$282K
BFK
3250
DELISTED
BlackRock Municipal Income Trust
BFK
$283K ﹤0.01%
28,125
-3,840
-12% -$37.4K

Similar funds

Raymond James & Associates's Q4 2022 Portfolio in Review

As of Q4 2022, Raymond James & Associates held 4,156 positions worth $109B, up 10% from $98.8B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Raymond James & Associates's Q4 2022 filing shows 227 new, 1,649 increased, 1,885 reduced and 242 closed positions. Its largest new stake was Rentokil: 285,133 shares worth $8.78M. The largest sale was iShares Expanded Tech Sector ETF, an estimated $79.2M.

By sector, the portfolio is most concentrated in Technology at 13% of assets, down from 13% a quarter earlier, followed by Healthcare and Financials.

  • Raymond James & Associates's largest Q4 2022 buy was Rentokil: 285,133 shares worth $8.78M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q4 2022, an estimated $169M increase.
  • Raymond James & Associates's biggest Q4 2022 reduction was iShares Expanded Tech Sector ETF, cutting an estimated $79.2M.
  • Raymond James & Associates fully exited Change Healthcare Inc. Common Stock in Q4 2022, selling an estimated $53.3M.
  • Raymond James & Associates's ten largest holdings make up 23% of its $109B portfolio in Q4 2022.
  • Raymond James & Associates opened 227 new positions and closed 242 in Q4 2022.
  • Raymond James & Associates's portfolio value rose 10% quarter-over-quarter to $109B.

Based on Raymond James & Associates's 13F filing for Q4 2022, filed 8 Feb 2023.